Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia
Condition(s):Essential ThrombocytopeniaLast Updated:November 15, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Essential ThrombocytopeniaLast Updated:November 15, 2023Recruiting
Condition(s):Essential ThrombocytopeniaLast Updated:January 29, 2024Recruiting
Condition(s):Hepatitis B, ChronicLast Updated:April 5, 2022Recruiting
Condition(s):Chronic HBV InfectionLast Updated:March 31, 2023Recruiting
Condition(s):Chronic Hepatitis B; Intermediate to High Risk of HCCLast Updated:May 25, 2023Recruiting
Condition(s):AIDS; Hepatitis BLast Updated:August 14, 2023Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:March 31, 2022Recruiting
Condition(s):Chronic Hepatitis BLast Updated:August 8, 2022Not yet recruiting
Condition(s):Adult T-cell Leukemia-Lymphoma; ATLLLast Updated:January 2, 2024Recruiting
Condition(s):Hepatitis BLast Updated:May 8, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.